Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 39776 - 39800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Etoposide	Approved Investigational	GDF15	9518	upregulated	Etoposide results in increased expression of GDF15 mRNA	19p13.11	A22582 A21499
Etoposide	Approved Investigational	GLS2	27165	upregulated	Etoposide results in increased expression of GLS2 mRNA	12q13.3	A21863
Etoposide	Approved Investigational	GRPEL1	80273	downregulated	Etoposide results in decreased expression of GRPEL1 mRNA	4p16.1	A21499
Etoposide	Approved Investigational	HAMP	57817	downregulated	Etoposide results in decreased expression of HAMP mRNA	19q13.12	A20683
Etoposide	Approved Investigational	HBEGF	1839	upregulated	Etoposide results in increased expression of HBEGF mRNA	5q31.3	A22581
Etoposide	Approved Investigational	HBP1	26959	downregulated	Etoposide results in decreased expression of HBP1 mRNA	7q22.3	A21499
Etoposide	Approved Investigational	HIC1	3090	upregulated	Etoposide results in increased expression of HIC1 mRNA	17p13.3	A22592
Etoposide	Approved Investigational	IER5	51278	upregulated	Etoposide results in increased expression of IER5 mRNA	1q25.3	A21863
Etoposide	Approved Investigational	ISG15	9636	upregulated	Etoposide results in increased expression of ISG15 mRNA	1p36.33	A21863
Etoposide	Approved Investigational	ISG20L2	81875	downregulated	Etoposide results in decreased expression of ISG20L2 mRNA	1q23.1	A21499
Etoposide	Approved Investigational	ITGA2B	3674	upregulated	Etoposide results in increased expression of ITGA2B mRNA	17q21.31	A21863
Etoposide	Approved Investigational	KIF1A	547	upregulated	Etoposide results in increased expression of KIF1A mRNA	2q37.3	A21863
Etoposide	Approved Investigational	KIF20A	10112	downregulated	Etoposide results in decreased expression of KIF20A mRNA	5q31.2	A21499
Etoposide	Approved Investigational	KLF6	1316	downregulated	Etoposide results in decreased expression of KLF6 mRNA	10p15.2	A21499
Etoposide	Approved Investigational	KRT80	144501	upregulated	Etoposide results in increased expression of KRT80 mRNA	12q13.13	A21863
Etoposide	Approved Investigational	LGALS7	3963	upregulated	Etoposide results in increased expression of LGALS7 mRNA	19q13.13	A21863
Etoposide	Approved Investigational	LHX2	9355	downregulated	Etoposide results in decreased expression of LHX2 mRNA	9q33.3	A21499
Etoposide	Approved Investigational	LRRC47	57470	downregulated	Etoposide results in decreased expression of LRRC47 mRNA	1p36.32	A21499
Etoposide	Approved Investigational	LTBR	4055	upregulated	Etoposide results in increased expression of LTBR mRNA	12p13	A21152
Etoposide	Approved Investigational	MAP2K3	5606	upregulated	Etoposide results in increased expression of MAP2K3 mRNA	17p11.2	A20666
Etoposide	Approved Investigational	MAP3K5	4217	downregulated	Etoposide results in decreased expression of MAP3K5 mRNA	6q23.3	A20666
Etoposide	Approved Investigational	MCM10	55388	downregulated	Etoposide results in decreased expression of MCM10 mRNA	10p13	A21499
Etoposide	Approved Investigational	MCM2	4171	downregulated	Etoposide results in decreased expression of MCM2 mRNA	3q21.3	A22582
Etoposide	Approved Investigational	MCM6	4175	downregulated	Etoposide results in decreased expression of MCM6 mRNA	2q21.3	A22582
Etoposide	Approved Investigational	MCM7	4176	downregulated	Etoposide results in decreased expression of MCM7 mRNA	7q22.1	A22582

Displaying entries 39776 - 39800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability